News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,956 Results
Type
Article (8038)
Company Profile (140)
Press Release (477777)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166768)
Career Advice (306)
Deals (25740)
Drug Delivery (7)
Drug Development (52879)
Employer Resources (14)
FDA (9762)
Job Trends (8577)
News (238247)
Policy (17930)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33154)
ALS (108)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (280)
Approvals (10401)
Artificial intelligence (329)
ASCO (159)
Autoimmune disease (219)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6958)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (518)
Cancer (3747)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (178)
CDMO (13)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (48026)
Collaboration (1274)
Commercialization (3)
Compensation (1525)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (800)
Cystic fibrosis (87)
Data (5835)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (352)
Diagnostics (4209)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73746)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88080)
Executive appointments (712)
FDA (12471)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (940)
Gene editing (126)
Generative AI (9)
Gene therapy (331)
GLP-1 (294)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9367)
Hematology (94)
HIV (54)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (161)
Infectious disease (950)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (259)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (535)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (560)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8676)
Medtech (8832)
Mergers & acquisitions (14406)
Metabolic disorders (724)
mRNA (61)
Multiple sclerosis (108)
NASH (4)
Neurodegenerative disease (226)
Neuropsychiatric disorders (40)
Neuroscience (1865)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (205)
Partnered (12)
Patents (494)
Patient recruitment (528)
Patient selection (1)
Peanut (32)
People (41343)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15514)
Phase 2 (21447)
Phase 3 (14458)
Pipeline (7658)
Policy (18)
Postmarket research (1571)
Preclinical (6552)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (586)
Real estate (3022)
Recruiting (6)
Regenerative medicine (1)
Regulatory (14934)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (160)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (75)
Women's health (86)
Date
Today (70)
Last 7 days (381)
Last 30 days (1394)
Last 365 days (19137)
2026 (13496)
2025 (19252)
2024 (22986)
2023 (26541)
2022 (34586)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17494)
2017 (18765)
2016 (17918)
2015 (24263)
2014 (21679)
2013 (18138)
2012 (20222)
2011 (20440)
2010 (20332)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17951)
Australia (2106)
California (12308)
Canada (3225)
China (542)
Colorado (494)
Connecticut (427)
Delaware (213)
Europe (24688)
Florida (1847)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (725)
India (52)
Indiana (321)
Iowa (16)
Japan (419)
Kansas (102)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1227)
Massachusetts (8082)
Michigan (312)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2685)
New Mexico (12)
New York (2889)
North Carolina (1314)
North Dakota (4)
Northern California (6189)
Ohio (292)
Oklahoma (14)
Oregon (16)
Pennsylvania (2292)
Puerto Rico (21)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5120)
Tennessee (123)
Texas (1996)
United States (39910)
Utah (369)
Vermont (1)
Virginia (158)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,956 Results for "pendopharm inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pendopharm announces the commercialization of Buccolam® in Canada
March 1, 2026
·
2 min read
Press Releases
Pendopharm Announces the Approval of Yorvipath® (palopegteriparatide injection) for the Treatment of Chronic Hypoparathyroidism in Adults
February 9, 2026
·
4 min read
Business
Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal, Monovisc, and Orthovisc
Pendopharm is pleased to announce the renewal of its exclusive distribution agreement with Anika Therapeutics Inc (NASDAQ: ANIK) (Anika) for Cingal ® , Monovisc ® and Orthovisc ® through the end of 2030.
May 16, 2024
·
2 min read
Press Releases
Pendopharm® and KalVista® Partner to Bring First Oral On-Demand HAE Treatment to Canada
June 27, 2025
·
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
·
4 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
·
4 min read
Press Releases
Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)
September 11, 2024
·
3 min read
Press Releases
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
September 3, 2026
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
1 of 48,596
Next
